TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

Session comprising selected PCR London Valves 2022 Late-Breaking Trial submissions in collaboration with EuroIntervention

Anchorperson: D. Capodanno

Moderator: A. Baumbach

Summary

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Learning Objectives

To hear the latest evidence evidence concerning new transcatheter valve devices
To learn more about emerging innovative devices
To share highlighted content from the EuroIntervention journal

Presentations available when logged in:

TRISCEND study one-year outcomes: transfemoral transcatheter tricuspid valve replacement
Transcatheter aortic valve replacement with the Self-Expanding ACURATE neo2: haemodynamic performance and clinical outcomes
Transcatheter tricuspid valve replacement with the LuX-Valve system one-year results of a multicentre, first-in-man experience

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

Session comprising selected PCR London Valves 2022 Late-Breaking Trial submissions in collaboration with EuroIntervention

Learning Objectives

Log in or create account for free